好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Patterns of Drop Seizure Outcome after Corpus Callosotomy in Children
Epilepsy/Clinical Neurophysiology (EEG)
P11 - Poster Session 11 (11:45 AM-12:45 PM)
11-010

We assessed patterns of drop seizure frequency and seizure types at 3 and 12 months following complete CC and at last follow-up.

Corpus callosotomy (CC) is a palliative surgical procedure that is effective in reducing drop seizures in children with refractory generalized epilepsy.

This was a retrospective, single-institution case series of patients <19 years who underwent complete CC between 2009-2024. Complete CC was achieved by open craniotomy or laser interstitial thermal therapy (LITT). Drop seizures included atonic, tonic, and myoclonic seizures that led to falls. Seizure outcomes were assessed at 3-month, 12-month, and last follow-up. Responders were patients with ≥50% drop seizure reduction compared to pre-CC seizure frequency. McNemar’s test for paired categorical data was performed to evaluate changes in seizure types between 3-month and last follow-up. 

Seventeen patients were included (41% female; median age at epilepsy onset 1 year, IQR 0.5-2.0 and at surgery 10 years, IQR 4-13). Complete CC was performed by open craniotomy in 59% and by LITT in the remaining. Responder rate was 82% at 3-month, 65% at 12-month, and 76% at last follow-up (median follow-up of 4 years, IQR 1-8). Seizure types among 12 patients at 3-month were tonic 58%, atonic 33%, myoclonic 8%, multiple 15.4%. Seizure types among 14 patients were tonic 79%,  atonic 29%, myoclonic 14%, multiple 42.9% at 12-month; tonic 50%, atonic 36%, myoclonic 57%, multiple 37.5% at last follow-up. Although myoclonic seizures and multiple seizure types increased over time, neither reached statistical significance (myoclonic seizures, p=0.06; multiple seizure types p=0.06).

Complete CC led to sustained drop seizure reduction in about 75% of children. Drop seizure types varied over time and were less predictable. CC remains an effective palliative option for children with refractory drop seizures, with durable benefit in drop seizure reduction. 
Authors/Disclosures
Alexander Yucht
PRESENTER
Mr. Yucht has nothing to disclose.
Ming-Chen Tsai, MD (Tri-Service General Hospital, National Defense Medical Center) Dr. Tsai has nothing to disclose.
Kai Miller (Mayo Clinic) Kai Miller has nothing to disclose.
Anthony L. Fine, MD (Mayo Clinic) The institution of Dr. Fine has received research support from Neurocrine Biosciences. The institution of Dr. Fine has received research support from American Board of Psychiatry and Neurology.
Katherine C. Nickels, MD, FAAN (Mayo Clinic) The institution of Dr. Nickels has received research support from Zogenix. The institution of Dr. Nickels has received research support from Marinus. The institution of Dr. Nickels has received research support from Bio-Pharm Solutions. The institution of Dr. Nickels has received research support from Pediatric Epilepsy Research Foundation. Dr. Nickels has received personal compensation in the range of $500-$4,999 for serving as a Faculty with J. Kiffin Penry 好色先生al Programs.
Donnie K. Starnes II, MD (Mayo School of Graduate Medical 好色先生) Dr. Starnes has nothing to disclose.
Elaine C. Wirrell, MD, FAAN (Mayo Clinic/Dept of Child Neurology) Dr. Wirrell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biocodex. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRIN. Dr. Wirrell has received publishing royalties from a publication relating to health care.
Paul E. Youssef, DO (Mayo Clinic) Dr. Youssef has nothing to disclose.
Lily Wong-Kisiel, MD, FAAN (Mayo Clinic) Dr. Wong-Kisiel has nothing to disclose.